NO874364D0 - Antivirus-immunoterapeutisk middel og fremstilling derav. - Google Patents

Antivirus-immunoterapeutisk middel og fremstilling derav.

Info

Publication number
NO874364D0
NO874364D0 NO874364A NO874364A NO874364D0 NO 874364 D0 NO874364 D0 NO 874364D0 NO 874364 A NO874364 A NO 874364A NO 874364 A NO874364 A NO 874364A NO 874364 D0 NO874364 D0 NO 874364D0
Authority
NO
Norway
Prior art keywords
preparation
immunotherapeutic agent
antivirus
man
present
Prior art date
Application number
NO874364A
Other languages
English (en)
Norwegian (no)
Inventor
William L Ragland
Original Assignee
William L Ragland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William L Ragland filed Critical William L Ragland
Publication of NO874364D0 publication Critical patent/NO874364D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO874364A 1985-10-08 1987-10-20 Antivirus-immunoterapeutisk middel og fremstilling derav. NO874364D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/785,070 US4744984A (en) 1985-10-08 1985-10-08 Antiviral immunotherapeutic agent and preparation thereof
PCT/US1986/002118 WO1987002249A1 (fr) 1985-10-08 1986-10-08 Agent immunotherapeutique antiviral et sa preparation

Publications (1)

Publication Number Publication Date
NO874364D0 true NO874364D0 (no) 1987-10-20

Family

ID=25134365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874364A NO874364D0 (no) 1985-10-08 1987-10-20 Antivirus-immunoterapeutisk middel og fremstilling derav.

Country Status (8)

Country Link
US (1) US4744984A (fr)
EP (1) EP0238657B1 (fr)
AT (1) ATE73347T1 (fr)
AU (1) AU605116B2 (fr)
CA (1) CA1293190C (fr)
DE (1) DE3684305D1 (fr)
NO (1) NO874364D0 (fr)
WO (1) WO1987002249A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0649659B2 (ja) * 1988-05-26 1994-06-29 ニカヘルス プロダクツ,リミテッド 抗ウイルス及び抗菌組成物並びに使用方法
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
BR9406496A (pt) * 1993-01-29 1996-01-02 Vetrepharm Inc Processo e composição para estimulação do sistema imunológico em um ser humano ou animal
EP0714305B1 (fr) * 1993-08-27 2001-12-19 Vetrepharm, Inc. Composition et procede servant a stimuler les capacites de reproduction
AU726330B2 (en) * 1993-08-27 2000-11-02 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
RU2040932C1 (ru) * 1993-12-17 1995-08-09 Крестьянское хозяйство "Агрофирма Дижа" Препарат, влияющий на тканевой обмен и применение штамма гриба fusarium sambucinum fuckel var ossicolum (berk.et curf) bilai для его получения
DE4422859C2 (de) * 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
US6303295B1 (en) * 1995-07-14 2001-10-16 University Of Georgia Research Foundation, Inc. Selenoproteins, coding sequences and methods
AUPO359396A0 (en) 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
AU727781B2 (en) * 1997-04-02 2000-12-21 Bioniche Life Sciences Inc. Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease
KR100533576B1 (ko) 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
EP1867718B1 (fr) * 1999-12-13 2010-01-20 Bioniche Life Sciences Inc. Oligonucléotides synthétiques utiles du point de vue thérapeutique
CA2395493C (fr) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. L'acide hyaluronique dans le traitement du cancer
NZ527322A (en) 2001-01-04 2005-07-29 Univ Saskatchewan EHEC cell culture supernatant vaccine
JP4859341B2 (ja) * 2001-07-19 2012-01-25 昭 林 ヒト免疫療法
CN1296059C (zh) * 2003-04-04 2007-01-24 张素琴 草分支杆菌免疫液
WO2005042746A1 (fr) 2003-10-31 2005-05-12 The University Of British Columbia Agressines bacteriennes et utilisations
ES2231037B1 (es) * 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
HRP20140102T1 (hr) 2007-06-01 2014-03-28 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Cjepivo za prevenciju relapsa raka dojke
KR20170097234A (ko) 2008-12-10 2017-08-25 더 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신, 인코포레이티드 유방암 재발 예방용 백신
WO2011020094A1 (fr) * 2009-08-14 2011-02-17 The Board Of Regents Of The University Of Texas System Utilisation d'arn simple brin synthétique (arnss) comme agent thérapeutique pour activer une réponse immunitaire dépendante de nod2 contre une infection virale
CN105943559A (zh) * 2010-10-13 2016-09-21 特莱斯塔治疗知识产权公司 细菌核糖核酸细胞壁组合物及其制备和使用方法
ITTO20120346A1 (it) 2012-04-18 2013-10-19 Turmond S P A Coltello multiplo rotante per il taglio longitudinale di nastri
BR112015001390B1 (pt) 2012-07-26 2024-04-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc Proteína de fusão, ácido nucleico isolado e uso de uma composição de vacina
EP2777711A1 (fr) 2013-03-11 2014-09-17 Icon Genetics GmbH Vaccin contre le cancer her2/neu
US10226520B2 (en) 2014-03-04 2019-03-12 The Board Of Regents Of The University Of Texa System Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination
US9579370B2 (en) 2014-03-04 2017-02-28 The Board Of Regents Of The University Of Texas System Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination
WO2017011919A1 (fr) 2015-07-22 2017-01-26 University Of Saskatchewan Vaccins contre mycoplasma et leurs utilisations
US11788631B2 (en) * 2020-02-28 2023-10-17 Columbia Insurance Company Barrel valve
WO2021185851A1 (fr) 2020-03-17 2021-09-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions de vaccin pour la prévention et le traitement du vih
BR112022021258A2 (pt) 2020-04-20 2023-01-17 Univ Saskatchewan Composições e métodos para prevenir, controlar e diagnosticar infecções micobacterianas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2184531B1 (fr) * 1972-05-19 1975-10-17 Anvar
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4520019A (en) * 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
US4744984A (en) 1988-05-17
ATE73347T1 (de) 1992-03-15
AU605116B2 (en) 1991-01-10
DE3684305D1 (de) 1992-04-16
CA1293190C (fr) 1991-12-17
WO1987002249A1 (fr) 1987-04-23
EP0238657A1 (fr) 1987-09-30
AU6525886A (en) 1987-05-05
EP0238657A4 (fr) 1988-05-31
EP0238657B1 (fr) 1992-03-11

Similar Documents

Publication Publication Date Title
NO874364D0 (no) Antivirus-immunoterapeutisk middel og fremstilling derav.
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
EP0199479A3 (en) Ozone decontamination of blood and blood products
IT7909403A0 (it) 2'-deossi-5(2-alogenovinil)-uridina e suo metodo di preparazione in specie per trattamento di infezioni da erpes
ATE73663T1 (de) Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DK534188D0 (da) Hidtil ukendt vaccine
DE3780091D1 (de) Behandlung von pilzinfektionen.
AU7679787A (en) Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
DE3777861D1 (de) Behandlung von gasen.
JPS54110310A (en) Inactivating agent of virus within human or animal body and production thereof
NO943653D0 (no) Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon
DE69230643D1 (de) Methode zur behandlung von viralen infektionen
NO880946L (no) Fremgangsmaate for fremstilling av terapeutisk preparat inneholdende dsrna og lymfokin.
PT600396E (pt) Vacinas contra protozoarios intestinais
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
ES2159287T3 (es) Peptidos hemorreguladores.
DE69127713D1 (de) Behandlung von Abgasen, die Silikon- und/oder Phosphorverbindungen enthalten
DK82892D0 (da) Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
NL194153B (nl) Preparaat bestemd voor de profylaxe of behandeling van protozoÙninfecties bij dieren.
NL7902450A (nl) Farmaceutisch preparaat met anti-complementaire wer- king, werkwijze voor de bereiding daarvan alsmede werk- wijze voor het behandelen van nephritis.
DE69126977D1 (de) Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier
MX9400210A (es) Tratamiento de infecciones virales.
NO930401D0 (no) Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav